Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Ventricular Dysfunction, Left D018487 33 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Sclerosis D012598 5 associated lipids
Atherosclerosis D050197 85 associated lipids
beta-Thalassemia D017086 5 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Coronary Stenosis D023921 6 associated lipids
Bacteremia D016470 9 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Thromboangiitis Obliterans D013919 4 associated lipids
Menorrhagia D008595 4 associated lipids
Dyslipidemias D050171 7 associated lipids
Pregnancy Complications D011248 19 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Cat Diseases D002371 12 associated lipids
Ductus Arteriosus, Patent D004374 5 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Weight Loss D015431 56 associated lipids
Endotoxemia D019446 27 associated lipids
Tooth, Impacted D014095 9 associated lipids
Blister D001768 16 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Lupus Nephritis D008181 8 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Weil Disease D014895 2 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Sneezing D012912 6 associated lipids
Helicobacter Infections D016481 21 associated lipids
Infertility D007246 3 associated lipids
Embolism, Fat D004620 4 associated lipids
Polycystic Kidney Diseases D007690 12 associated lipids
Heart Septal Defects D006343 2 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
Pneumonia, Viral D011024 3 associated lipids
Intermittent Claudication D007383 6 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Hydatidiform Mole D006828 3 associated lipids
Hemorrhagic Fever with Renal Syndrome D006480 3 associated lipids
Venous Thrombosis D020246 11 associated lipids
Mastocytosis D008415 5 associated lipids
Asthenia D001247 5 associated lipids
Chest Pain D002637 4 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Fistula D005402 8 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Varicose Veins D014648 7 associated lipids
Tachycardia, Paroxysmal D013614 2 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Macular Edema D008269 3 associated lipids
Aortic Rupture D001019 3 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Diseases in Twins D004200 4 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Aortic Arch Syndromes D001015 2 associated lipids
Mixed Connective Tissue Disease D008947 2 associated lipids
Edema, Cardiac D004489 1 associated lipids
Oligomenorrhea D009839 1 associated lipids
Yang Deficiency D016711 3 associated lipids
Bluetongue D001819 1 associated lipids
Retinal Vein Occlusion D012170 2 associated lipids
Foot Rot D005535 1 associated lipids
Frostbite D005627 1 associated lipids
Strongyle Infections, Equine D013319 1 associated lipids
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Gastric Dilatation D013271 1 associated lipids
Stomach Volvulus D013277 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Malcolm KC and Fitzpatrick FA Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways. 1992 J. Pharmacol. Exp. Ther. pmid:1532033
Jin YR et al. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. 2005 J. Pharmacol. Exp. Ther. pmid:15328379
Ming HX et al. [Influence of single leaf Asarum himalaicum on renal function of rabbits]. 2004 Zhong Xi Yi Jie He Xue Bao pmid:15339444
Chen Z et al. [Correlation between TXB2, 6-Keto-PGF1alpha and liver metastasis in rats model with blood stasis]. 2003 Zhong Xi Yi Jie He Xue Bao pmid:15339561
He LQ et al. [Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy]. 2003 Zhong Xi Yi Jie He Xue Bao pmid:15339583
Dey A et al. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. 2004 Obes. Res. pmid:15340111
Nagai H et al. The effect of three novel thromboxane A2 receptor antagonists (S-1452, AA-2414 and ONO-3708) on the increase in pulmonary pressure caused by Forssman anaphylaxis in guinea-pigs. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1534171
Fiorucci S et al. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 2004 J. Am. Coll. Cardiol. pmid:15358033
Ganafa AA et al. Amlodipine attenuates oxidative stress-induced hypertension. 2004 Am. J. Hypertens. pmid:15363814
Di Nunno L et al. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal. 2004 J. Med. Chem. pmid:15369392
Mak IT et al. Cardiac pathologic effects of azidothymidine (AZT) in Mg-deficient mice. 2004 Cardiovasc. Toxicol. pmid:15371632
Xu L et al. [Effects of effective component from "qing kai ling" on endothelial cell of microvessel in MCAO rats]. 2004 Zhong Yao Cai pmid:15376390
Devi MM and Das UN Effect of prostaglandins against alloxan-induced cytotoxicity to insulin secreting insulinoma RIN cells in vitro. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15380818
Perneby C et al. Prothrombotic responses to exercise are little influenced by clopidogrel treatment. 2004 Thromb. Res. pmid:15381386
Hennekens CH et al. Terms and conditions: semantic complexity and aspirin resistance. 2004 Circulation pmid:15381661
Zhao GR et al. [Clinical study on relationship between sluggishness of lung-defensive qi and levels of vasoactive intestinal polypeptide and thromboxane B2]. 2004 Zhong Xi Yi Jie He Xue Bao pmid:15383251
DeRubertis FR and Craven PA Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat. 1992 Metab. Clin. Exp. pmid:1538647
Rebuzzi AG et al. Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. 1992 Am. Heart J. pmid:1539506
Walsh CJ et al. Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis. 1992 Arch Surg pmid:1540090
Yoshimura T et al. [Increased red-cell sodium-lithium countertransport activity and urinary 11-dehydrothromboxane B2 during pregnancy]. 1992 Nippon Sanka Fujinka Gakkai Zasshi pmid:1545169
Lam AN et al. Effect of red clover isoflavones on cox-2 activity in murine and human monocyte/macrophage cells. 2004 Nutr Cancer pmid:15456640
Vega-Ostertag M et al. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. 2004 Arthritis Rheum. pmid:15457460
Ascer E et al. Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. 1992 Ann Vasc Surg pmid:1547081
Chiang N et al. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15471991
Davì G et al. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:15472127
Park WH et al. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. 2004 Life Sci. pmid:15474558
Ikeuchi H et al. The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model. 1992 J Trauma pmid:1548723
Weyrich AS et al. The effects of testosterone on lipids and eicosanoids in cynomolgus monkeys. 1992 Med Sci Sports Exerc pmid:1549028
Chen BN et al. [Characteristic changes of vascular tension factors in diabetic arterial occlusion of lower extremities]. 2004 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:15495823
Noverr MC and Huffnagle GB Regulation of Candida albicans morphogenesis by fatty acid metabolites. 2004 Infect. Immun. pmid:15501745
Tsai CY et al. Effect of antibodies to double stranded DNA, purified from serum samples of patients with active systemic lupus erythematosus, on the glomerular mesangial cells. 1992 Ann. Rheum. Dis. pmid:1550397
Rocca B et al. Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 2004 Exp. Hematol. pmid:15504548
Chou DS et al. Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study. 2004 Lipids pmid:15506238
He W et al. Effects of the Chinese drugs for activating blood circulation on plasma TXB2 and 6-keto-PGF1alpha contents in rabbits with glucocorticoid-induced femoral head necrosis. 2004 J Tradit Chin Med pmid:15510809
Mori TA et al. Differential effect of aspirin on platelet aggregation in IDDM. 1992 Diabetes pmid:1551486
Ardaillou R et al. Glomerular tissue factor stimulates thromboxane synthesis in human platelets via thrombin generation. 1992 Kidney Int. pmid:1552709
Zhang L et al. Effects of thiol antioxidant on reduced nicotinamide adenine dinucleotide phosphate oxidase in hypertensive Dahl salt-sensitive rats. 2004 Free Radic. Biol. Med. pmid:15528040
Maynard PM et al. Effect of glutathione depletion on tissue and plasma prostacyclin and thromboxane in rats. 1992 Biochem. Pharmacol. pmid:1554377
Cardoni RL and Antúnez MI Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections. 2004 Mediators Inflamm. pmid:15545053
Vainio M et al. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. 2004 Acta Obstet Gynecol Scand pmid:15548142
Tawata M et al. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. 1992 Eur. J. Pharmacol. pmid:1555643
Logan JL et al. Dietary fish oil interferes with renal arachidonic acid metabolism in rats: correlations with renal physiology. 1992 Metab. Clin. Exp. pmid:1556945
Horiguchi T et al. [Protamine and pulmonary hypertension]. 1992 Kokyu To Junkan pmid:1557557
Toda N et al. Comparison of hypoxia-induced contraction in human, monkey, and dog coronary arteries. 1992 Am. J. Physiol. pmid:1558175
Chang Y et al. Mechanisms involved in the antiplatelet activity of ketamine in human platelets. 2004 Nov-Dec J. Biomed. Sci. pmid:15591773
Jacobson JM et al. Hyperbaric oxygen toxicity: role of thromboxane. 1992 J. Appl. Physiol. pmid:1559913
Gonzalez-Conejero R et al. Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? 2005 Stroke pmid:15604423
Feinkind L et al. Umbilical and uterine Doppler velocimetry and prostaglandin levels in preeclampsia. 1992 J Ultrasound Med pmid:1560497
Wu JX et al. Changes in somatostatin receptor expression of the pancreas and effectiveness of octreotide in rats with acute necrotizing pancreatitis. 2004 Chin J Dig Dis pmid:15612670
Oishi M and Mochizuki Y beta-Thromboglobulin and 11-dehydrothromboxane B in tension-type headache. 1998 Headache pmid:15613179
Berrougui H et al. Argan (Argania spinosa) oil lowers blood pressure and improves endothelial dysfunction in spontaneously hypertensive rats. 2004 Br. J. Nutr. pmid:15613254
Restori G et al. Effects of heparan-sulphate administration on clotting parameters and serum thromboxane B2 levels in cholesterol fed rabbits. 1992 Recenti Prog Med pmid:1561475
Macconi D et al. Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation. 1992 Am. J. Kidney Dis. pmid:1562019
Fan JG et al. [Dynamic changes of plasma levels of prostacycline and thromboxane A2 and their correlation with the severity of hepatic injury in rats with nonalcoholic fatty liver disease]. 2004 Zhonghua Gan Zang Bing Za Zhi pmid:15623379
Sciulli MG et al. Platelet activation in patients with colorectal cancer. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15626589
Liu P et al. [Effects of the extracts from decoction for resuscitation and its component herbs on PGI2, TXA2 and NO release from rat vascular endothelial cells under hypoxia in vitro]. 2004 Zhongguo Zhong Yao Za Zhi pmid:15631091
Ohnishi A et al. Effects of a sustained thromboxane synthase inhibition on exercise-induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans. 1992 Clin. Pharmacol. Ther. pmid:1563215
Yang JP et al. [Changes of the platelet function and serum anticardiolipin antibody in patients with pulmonary thromboembolism]. 2004 Zhonghua Jie He He Hu Xi Za Zhi pmid:15634381
Wang MS et al. [The effects of lupus anticoagulant on pulmonary thromboembolism]. 2004 Zhonghua Jie He He Hu Xi Za Zhi pmid:15634384
Watanabe H et al. Effects of salt loading on blood pressure in mice lacking the prostanoid receptor gene. 2005 Circ. J. pmid:15635218
Vähä-Eskeli K et al. Responses of placental steroids, prostacyclin and thromboxane A2 to thermal stress during pregnancy. 1992 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:1563566
Spinarová L et al. [Physical training in patients with chornic heart failure: haemodynamics, effects]. 2001 Vnitr Lek pmid:15635849
Franz KB A functional biological marker is needed for diagnosing magnesium deficiency. 2004 J Am Coll Nutr pmid:15637224
Mihai K et al. Balance of prostacyclin and thromboxane in offspring of parents with premature coronary arterial disease. 1992 Int. J. Cardiol. pmid:1563873
Maruyama T et al. Thromboxane-dependent portopulmonary hypertension. 2005 Am. J. Med. pmid:15639216
Esser R et al. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. 2005 Br. J. Pharmacol. pmid:15655513
Saumweber DM et al. Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS. 1992 Transplant. Proc. pmid:1566436
Chan CP et al. Inhibition of cyclooxygenase activity, platelet aggregation and thromboxane B2 production by two environmental toxicants: m- and o-cresol. 2005 Toxicology pmid:15664436
Pratschke J et al. Allogeneic heart transplantation following xenografting. 1992 Transplant. Proc. pmid:1566482
Park WH et al. Anti-inflammatory effects of a traditional Korean herbal formulation, Silsosangami, consisting of seven medicinal herbs: effect on hemolysis, neutrophil function, and gene expressions of iNOS and COX-2. 2004 Vascul. Pharmacol. pmid:15664882
Massicot F et al. In vitro assessment of renal toxicity and inflammatory events of two protein phosphatase inhibitors cantharidin and nor-cantharidin. 2005 Basic Clin. Pharmacol. Toxicol. pmid:15667592
Lee GY et al. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. 2005 Thromb. Res. pmid:15668191
Kawamoto M et al. Acute pulmonary edema after intravenous liquid halothane in dogs. 1992 Anesth. Analg. pmid:1567044
Murphy CT and Westwick J Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. 1992 Biochem. J. pmid:1567363
Ye T et al. [Insulin resistance and effects of intravenous acute saline load on renal production of prostaglandin I2 and thromboxane A2 in salt-sensitive hypertensive patients]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15684012
He J et al. Treatment of unstable angina pectoris with modified nuan gan jian--a report of 33 cases. 2004 J Tradit Chin Med pmid:15688691
Arruzazabala ML et al. Effects of d-003, a new substance purified from sugar cane wax, on platelet aggregation and plasma levels of arachidonic acid metabolites in healthy volunteers. 2004 Int J Clin Pharmacol Res pmid:15689052
Sullivan JC et al. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. 2005 Hypertension pmid:15699443
Masferrer JL et al. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. 1992 Proc. Natl. Acad. Sci. U.S.A. pmid:1570314
Walenga JM et al. Hemostatic abnormalities in total artificial heart patients as detected by specific blood markers. 1992 Ann. Thorac. Surg. pmid:1570981
Arakawa K et al. Bradykinin B2 receptor antagonist FR173657 ameliorates small bowel ischemia-reperfusion injury in dogs. 2005 Dig. Dis. Sci. pmid:15712633
Walshaw PE et al. Diuretic and non-diuretic actions of furosemide: effects of probenecid. 1992 Clin Invest Med pmid:1572111
Trebino CE et al. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. 2005 J. Biol. Chem. pmid:15722356
Persico N et al. Transdermal hormone replacement therapy and Doppler findings in normal and overweight postmenopausal patients. 2004 Gynecol. Endocrinol. pmid:15726916
Gama de Abreu M et al. Vaporized perfluorohexane attenuates ventilator-induced lung injury in isolated, perfused rabbit lungs. 2005 Anesthesiology pmid:15731599
Saloheimo P et al. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. 2005 Thromb. Res. pmid:15733969
Lappegård KT et al. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. 2005 Ann. Thorac. Surg. pmid:15734405
Fimognari FL et al. Nocturnal rise of urinary thromboxane B 2 in patients with coronary artery disease. 2005 Thromb. Haemost. pmid:15735822
Mayer AM et al. Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines. 2005 BMC Pharmacol. pmid:15762999
Kalaitzis C et al. Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats. 2005 Scand. J. Urol. Nephrol. pmid:15764265
Oliveira RL et al. Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2. 2005 Int. J. Cardiol. pmid:15771927
García-Saura MF et al. Effects of chronic quercetin treatment in experimental renovascular hypertension. 2005 Mol. Cell. Biochem. pmid:15792364
Léger CL et al. A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes. 2005 Eur J Clin Nutr pmid:15798774
Lukaszyk A et al. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175). 1992 Thromb. Res. pmid:1579898
Cryer B et al. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. 2005 Clin Ther pmid:15811481
Heard SO et al. Dietary enrichment with omega-3 fatty acids partially protects against lipopolysaccharide-induced atrial depression in rats. 1992 Circ. Shock pmid:1582005
Awad AS et al. Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats. 2005 Am. J. Hypertens. pmid:15831366
De Candia E et al. Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. 2005 Int. J. Cardiol. pmid:15837078
Capone ML et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. 2005 J. Am. Coll. Cardiol. pmid:15837265
Chang P et al. Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver. 2005 Dig. Dis. Sci. pmid:15844712